Cobb Stuart
Officer at NGNE
- Sold, on record
- $244k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Mar 13, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NGNENeurogene Inc.Officer
Sales by reason
1
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice NGNENoticeMay 14, 2025 2025
Filed to sell 6,797 shares ($105k)
Cobb Stuart, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale NGNERoutineMay 14, 2025 same day
Sold 6,797 shares at $15.15 ($103k)
Cobb Stuart, Chief Scientific Officer
10b5-1 planSold 24.6% of holdings ($418k position)20,794 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice NGNENoticeMar 13, 2026 +303 days
Filed to sell 6,797 shares ($152k)
Cobb Stuart, Officer
10b5-1 planFiling
- 4 Form 4 sale NGNERoutineMar 13, 2026 same day
Sold 6,797 shares at $20.81 ($141k)
Cobb Stuart, Chief Scientific Officer
10b5-1 planSold 18.2% of holdings ($776k position)30,497 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Mar 17, 2026 | NGNE | Chief Scientific Officer | Form 4 sale | 6,797 | $141k | 18.2% | Routine | SEC |
| Mar 13, 2026 | Mar 13, 2026 | NGNE | Officer | Form 144 notice | 6,797 | $152k | Notice | SEC | |
| May 14, 2025 | May 15, 2025 | NGNE | Chief Scientific Officer | Form 4 sale | 6,797 | $103k | 24.6% | Routine | SEC |
| May 14, 2025 | May 14, 2025 | NGNE | Officer | Form 144 notice | 6,797 | $105k | Notice | SEC |